Publications by authors named "David Fogelman"

Claim this Profile
U
Use of Real-World Data to Support Economic Evaluations of Tumor-Agnostic Therapies: Challenges Remain.
Kate Young, Grant McCarthy, Raquel Aguiar-Ibáñez, Dave Gelb, Wenjun Zhong, David Fogelman

Value Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth Attenuation Therapy: Ongoing Ethical and Practical Challenges 20 Years Post Ashley.
Stephen D Brown, Kerri O Kennedy, Faye F Holder-Niles, Irina A Anselm, Brian D Snyder, David Fogelman

Am J Bioeth· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between lower limb spasticity and cryptorchidism in males with cerebral palsy.
Eric M Bortnick, Tanya Logvinenko, Hsin-Hsiao Scott Wang, David J Fogelman, Benjamin J Shore

Dev Med Child Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer.
Thierry André, Filippo Pietrantonio, Antonio Avallone, Mahmut Gumus, Lucjan Wyrwicz, David Fogelman

Future Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer.
Takayuki Yoshino, Thierry Andre, Tae Won Kim, Wei Peng Yong, Kai-Keen Shiu, David Fogelman

Cancer Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer.
Aislyn Schalck, Donastas Sakellariou-Thompson, Marie-Andrée Forget, Emi Sei, Tara G Hughes, David R Fogelman

Cancer Discov· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer.
Jennifer S Davis, Janelle C Chavez, Melissa Kok, Yazmin San Miguel, Hwa Young Lee, David Fogelman

JAMA Netw Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors: A Nonrandomized Clinical Trial.
Daniel M Halperin, Suyu Liu, Arvind Dasari, David Fogelman, Priya Bhosale

JAMA Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Luis A Diaz, Kai-Keen Shiu, Tae-Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, David Fogelman

Lancet Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States.
Raquel Aguiar-Ibáñez, Chloë Hardern, Frank van Hees, Dawn Lee, Anubhav Patel, David Fogelman

J Med Econ· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Clinical and Molecular Characterization of -Mutant Colorectal Cancer.
Jason T Henry, Oluwadara Coker, Saikat Chowdhury, John Paul Shen, Van K Morris, David Fogelman

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mendelian etiologies identified with whole exome sequencing in cerebral palsy.
Maya Chopra, Dustin L Gable, Jamie Love-Nichols, Alexa Tsao, Shira Rockowitz, David Fogelman

Ann Clin Transl Neurol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients.
Chirayu Mohindroo, Merve Hasanov, Jane E Rogers, Wenli Dong, Laura R Prakash, David R Fogelman

Cancer Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials.
Milind Javle, Einat Shacham-Shmueli, Lianchun Xiao, Gauri Varadhachary, Naama Halpern, David Fogelman

JAMA Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low C and improved tolerability, in patients with solid tumors.
Jaffer A Ajani, Milind Javle, Cathy Eng, David Fogelman, Jackie Smith

Invest New Drugs· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFOXIRI Versus Doublet Regimens in Right-Sided Metastatic Colorectal Cancer: Focus on Subsequent Therapies and Impact on Overall Survival.
Alexandre A Jácome, Bryan Kee, David Fogelman, Arvind Dasari, Imad Shureiqi

Clin Colorectal Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism.
Alexandre A Jácome, Aki Ohinata, Armeen Mahvash, Michael J Overman, Bryan Kee, David Fogelman

Clin Colorectal Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer.
Giampaolo Perri, Laura Prakash, Giuseppe Malleo, Andrea Caravati, Gauri R Varadhachary, David Fogelman

Ann Surg Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.
Giampaolo Perri, Laura Prakash, Wei Qiao, Gauri R Varadhachary, Robert Wolff, David Fogelman

JAMA Surg· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials.
Timothy A Lin, Clifton David Fuller, Vivek Verma, Walker Mainwaring, Andres F Espinoza, David R Fogelman

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinoma.
Jane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, Chirayu Mohindroo, Rachna T Shroff, David R Fogelman

Cancer Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma.
Giampaolo Perri, Laura Prakash, Wei Qiao, Gauri R Varadhachary, Robert Wolff, David Fogelman

Ann Surg· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer.
Mona Kamal, Xin Shelley Wang, Qiuling Shi, Tito Mendoza, Araceli Garcia-Gonzalez, David R Fogelman

J Pain Symptom Manage· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older.
Jonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, Robert A Wolff, Gauri R Varadhachary, David R Fogelman

Pancreatology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer.
Eugene J Koay, Matthew H G Katz, Huamin Wang, Xuemei Wang, Laura Prakash, David Fogelman

JCO Precis Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis